nasal spray ghk cu GHK-Cu GHK-Cu Nasal Spray Support

In April 2026, the FDA removed the Category II restriction

Accordingly, emerging drug strategies aim to restore synaptic function by enhancing activity-dependent synaptic plasticity or preventing synapse loss in these disorders

Whether any of these analogs displaces native GHK-Cu in the research literature will depend on the next decade of comparative data

FTC Affiliate Disclosure This site contains affiliate links

For performance-focused readers, that is the point: not a promise of transformation, but a chance to support the parts of recovery that determine whether you stay active, build capacity, and keep doing what you love longer